Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | ABCB1 | P08183 | 6/20 | 0.54 |
| ▸ | ABCC1 | P33527 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | ACACB | O00763 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3045927 | 0.88 | CA9 (0.71) | CA9KDM4ETDP1ABCB1ABCC1 | |
| SCHEMBL3049161 | 0.85 | CA9 (0.78) | CA9KDM4ETDP1ABCB1ABCC1 | |
| SCHEMBL3058998 | 0.82 | L3MBTL1 (0.59) | CA9KDM4EABCB1ABCC1MAPT | |
| SCHEMBL3061384 | 0.78 | CA9 (0.70) | CA9KDM4ETDP1ABCB1ABCC1 | |
| SCHEMBL3054852 | 0.75 | CA9 (0.62) | CA9ABCB1ABCC1ABCG2LTA4H | |
| SCHEMBL3041525 | 0.75 | CA9 (0.73) | CA9KDM4ETDP1ABCB1ABCC1 | |
| SCHEMBL3059218 | 0.75 | SIGMAR1 (0.66) | CA9KDM4ETDP1ABCB1ABCC1 | |
| SCHEMBL3051287 | 0.74 | LMNA (0.74) | CA9KDM4EMAPTHTTNPSR1 | |
| SCHEMBL10675304 | 0.74 | ABCB1 (0.62) | CA9ABCB1ABCC1ABCG2LTA4H | |
| SCHEMBL3048314 | 0.73 | LTA4H (0.59) | CA9ABCB1ABCC1ALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8394825-B2 | Compound | STERIX LIMITED (GB) | 2013-03-12 | — | — | US | disclosed |
| US-20100222299-A1 | COMPOUND | STERIX LIMITED (GB) | 2010-09-02 | — | — | US | disclosed |
| CN-101677993-A | Compound (I) | STERIX LTD | 2010-03-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222299-A1 | COMPOUND | MKI67, VHL, MYC | CA9 1002/4885KDM4E 1083/4885TDP1 4235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.